Regeneron Pharmaceuticals | REGN - Ebitda


Regeneron Pharmaceuticals reported $1.66B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
AbbVie USD 3.69B 1.68B Mar/2026
Agenus USD -10.11M 19.02M Mar/2025
Agios Pharmaceuticals USD -108.66M 11.65M Mar/2026
Alnylam Pharmaceuticals USD 245.34M 59.15M Jun/2026
Amgen USD 3.86B 1.28B Mar/2026
Astellas Pharma JPY 98.93B 84.75B Mar/2026
AstraZeneca USD 5.16B 510M Jun/2026
Biogen USD 649.7M 76.5M Mar/2026
BioMarin Pharmaceutical USD 146.05M 170.22M Mar/2026
Bristol-Myers Squibb USD 4.24B 1.37B Mar/2026
Eli Lilly USD 12.14B 4.26B Dec/2025
Gilead Sciences USD 3.51B 489M Mar/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Incyte USD 778.57M 410.6M Jun/2026
Ionis Pharmaceuticals USD -64.53M 135.49M Mar/2026
J&J USD 8.27B 1.08B Mar/2026
Kyowa Hakko Kirin JPY 53.91B 36.74B Jun/2026
Merck USD -1.54B 7.84B Mar/2026
Moderna USD -1.26B 468M Mar/2026
Neurocrine Biosciences USD 193.3M 25.1M Mar/2026
Novartis USD 6.48B 1.19B Jun/2026
Novartis USD 5.41B 431M Mar/2026
Pfizer USD 5.99B 5.23B Mar/2026
Puma Biotechnology USD 729K 11.36M Jun/2024
Regeneron Pharmaceuticals USD 1.66B 695.2M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 2.72B 2.94B Mar/2026
Sarepta Therapeutics USD -252.2M 84.16M Dec/2025
Teva Pharmaceutical Industries USD 474M 581M Jun/2026
Ultragenyx Pharmaceutical USD -155M 55.57M Mar/2026
United Therapeutics USD 379.5M 83.4M Dec/2025
Vertex Pharmaceuticals USD 1.19B 195.3M Mar/2026